Results 271 to 280 of about 66,268 (303)

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source

Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis

FEBS Journal, 2006
Geoff McCaughan, Mark D. Gorrell
exaly  

Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

Hypertension, 2010
Nancy J Brown
exaly  

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Michael Benzaquen, Luca Borradori, Simone Cazzaniga   +2 more
exaly  

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

Current Medical Research and Opinion, 2011
Matteo Monami, Ilaria Dicembrini, Edoardo Mannucci   +2 more
exaly  

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source

Dipeptidyl Peptidase-4 in Cariometabolic Disease

The cardiovascular implications of modulating cell specific expression of the serine protease dipeptidyl peptidase-4 (DPP4) were investigated in a series of murine models of metabolic dysfunction-associated steatotic liver disease (MASLD), cardiometabolic disease and myocardial infarction. In vivo experiments were conducted using several genetic models,
openaire   +1 more source

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Critical Reviews in Clinical Laboratory Sciences, 2003
Anne-Marie Lambeir
exaly  

Dipeptidyl-peptidase-4-inhibitors/insulin degludec

Reactions Weekly, 2022
openaire   +1 more source